PCSK9 and Hypertension: Multiple linear regression confirmed PCSK9 E670G as an independent predictor of LDL-C levels, accounting for age, gender, smoking, hypertension, diabetes mellitus, BMI, and lipid-lowering agent use (p = 0.029).